A Guide To The Risks Of Investing In Avidity Biosciences Inc (RNA)

Avidity Biosciences Inc’s recently made public that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $27549.0 on Jun 17 ’25. In the deal valued at $30.24 per share,911 shares were sold. As a result of this transaction, Gallagher Kathleen P. now holds 50,392 shares worth roughly $1.88 million.

Then, KATHLEEN GALLAGHER bought 911 shares, generating $27,148 in total proceeds.

Before that, Flanagan W. Michael sold 20,000 shares. Avidity Biosciences Inc shares valued at $657,694 were divested by the Chief Scientific Officer at a price of $32.88 per share. As a result of the transaction, Flanagan W. Michael now holds 80,195 shares, worth roughly $2.99 million.

A number of analysts have revised their coverage, including Bernstein’s analysts, who began to cover the stock in late June with a ‘”an Outperform”‘ rating. Wolfe Research began covering RNA with “an Outperform” recommendation on June 17, 2025. Raymond James started covering the stock on June 11, 2025. It rated RNA as “a Strong buy”.

Price Performance Review of RNA

On Monday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock jump 3.95% to $37.34. Over the last five days, the stock has gained 8.04%. Avidity Biosciences Inc shares have fallen nearly -18.08% since the year began. Nevertheless, the stocks have risen 28.40% over the past one year.

How much short interest is there in Avidity Biosciences Inc?

A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2025-07-15, dropping by 84374.0 shares to a total of 16.26 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 16.34 million shares. There was a decline of -0.52%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.